Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation

Tissue Engineering - Part A

Volumn 18, Issue 13-14, 2012, Pages 1352-1364

  Zhang, Shichang ^a,b   Chen, Li ^a   Liu, Tao ^a,c   Zhang, Bo ^b   Xiang, Dedong ^a   Wang, Zhengguo ^b   Wang, Yingjie ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c 401 Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CELL CULTURE; FLOWCHARTING; MAMMALS; SELF ASSEMBLY; TISSUE;

ACUTE LIVER FAILURE; ALTERNATIVE SOURCE; CELL THERAPY; COCULTURE; CYTOKINES; DIFFERENT MECHANISMS; HEPATIC DIFFERENTIATION; HEPATIC FUNCTION; HEPATOCYTES; HUMAN HEPATOCYTES; HUMAN UMBILICAL CORD; IN-VITRO; INFLAMMATORY CYTOKINES; INTERLEUKIN1; LIVER INJURIES; LIVER REGENERATION; MESENCHYMAL STEM CELL; MOUSE SERUM; NOD-SCID MICE; NON-OBESE DIABETICS; PARACRINE; PRIMARY EFFECTS; RECEPTOR ANTAGONISTS; THERAPEUTIC POTENTIALS; TUMOR NECROSIS FACTORS;

STEM CELLS;

MUS;

BIOLOGICAL MARKER; CYTOKINE;

ACUTE LIVER FAILURE; ADULT; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE; CYTOLOGY; ENZYMOLOGY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; LIVER; LIVER CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PARACRINE SIGNALING; PATHOLOGY; SCID MOUSE; UMBILICAL CORD;

ADULT; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOKINES; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEPATOCYTES; HUMANS; LIVER; LIVER FAILURE, ACUTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; PARACRINE COMMUNICATION; UMBILICAL CORD;

EID: 84863888590     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0516     Document Type: Article

References (41)

1. Zern, M.A. Cell transplantation to replace whole liver transplantation. Gastroenterology 136, 767, 2009.
2. Soltys, K.A., Soto-Gutierrez, A., Nagaya, M., Baskin, K.M., Deutsch, M., Ito, R., Shneider, B.L., Squires, R., Vockley, J., Guha, C., Roy-Chowdhury, J., Strom, S.C., Platt, J.L., and Fox, I.J. Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol 53, 769, 2010.
3. Li, F., Liu, P., Liu, C., Xiang, D., Deng, L., Li, W., Wangensteen, K., Song, J., Ma, Y., Hui, L., Wei, L., Li, L., Ding, X., Hu, Y., He, Z., and Wang, X. Hepatoblast-like progenitor cells derived from embryonic stem cells can repopulate livers of mice. Gastroenterology 139, 2158, 2010.
4. Pera, M.F. Stem cells: the dark side of induced pluripotency. Nature 471, 46, 2011.
5. Liu, T., Zhang, S., Chen, X., Li, G., and Wang, Y. Hepatic differentiation of mouse embryonic stem cells in threedimensional polymer scaffolds. Tissue Eng Part A 16, 1115, 2010.
6. Lee, K.D., Kuo, T.K., Whang-Peng, J., Chung, Y.F., Lin, C.T., Chou, S.H., Chen, J.R., Chen, Y.P., and Lee, O.K. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40, 1275, 2004.
7. Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Quinn, G., Okochi, H., and Ochiya, T. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46, 219, 2007.
8. Newsome, P.N., Johannessen, I., Boyle, S., Dalakas, E., McAulay, K.A., Samuel, K., Rae, F., Forrester, L., Turner, M.L., Hayes, P.C., Harrison, D.J., Bickmore, W.A., and Plevris, J.N. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 124, 1891, 2003.
9. Mareschi, K., Ferrero, I., Rustichelli, D., Aschero, S., Gammaitoni, L., Aglietta, M., Madon, E., and Fagioli, F. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97, 744, 2006.
10. Shi, Y.Y., Nacamuli, R.P., Salim, A., and Longaker, M.T. The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plast Reconstr Surg 116, 1686, 2005.
11. Katsara, O., Mahaira, L.G., Iliopoulou, E.G., Moustaki, A., Antsaklis, A., Loutradis, D., Stefanidis, K., Baxevanis, C.N., Papamichail, M., and Perez, S.A. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrowderived mesenchymal stem cells. Stem Cells Dev 20, 1549, 2011.
12. Kern, S., Eichler, H., Stoeve, J., Kluter, H., and Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294, 2006.
13. Weiss, M.L., Anderson, C., Medicetty, S., Seshareddy, K.B., Weiss, R.J., VanderWerff, I., Troyer, D., and McIntosh, K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26, 2865, 2008.
14. Anzalone, R., Lo Iacono, M., Corrao, S., Magno, F., Loria, T., Cappello, F., Zummo, G., Farina, F., and La Rocca, G. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 19, 423, 2010.
15. Nekanti, U., Rao, V.B., Bahirvani, A.G., Jan, M., Totey, S., and Ta, M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev 19, 117, 2010.
16. Cho, P.S., Messina, D.J., Hirsh, E.L., Chi, N., Goldman, S.N., Lo, D.P., Harris, I.R., Popma, S.H., Sachs, D.H., and Huang, C.A. Immunogenicity of umbilical cord tissue derived cells. Blood 111, 430, 2008.
17. Kuo, T.K., Hung, S.P., Chuang, C.H., Chen, C.T., Shih, Y.R., Fang, S.C., Yang, V.W., and Lee, O.K. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134, 2111, 2008.
18. Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Osaki, M., Kato, T., Okochi, H., and Ochiya, T. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 24, 70, 2009.
19. Peng, L., Xie, D.Y., Lin, B.L., Liu, J., Zhu, H.P., Xie, C., Zheng, Y.B., and Gao, Z.L. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54, 820, 2011.
20. Klingemann, H. Discarded stem cells with a future? Expert Opin Biol Ther 6, 1251, 2006.
21. Hatlapatka, T., Moretti, P., Lavrentieva, A., Hass, R., Marquardt, N., Jacobs, R., and Kasper, C. Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng Part C Methods 17, 485, 2011.
22. Fan, C.G., Zhang, Q.J., and Zhou, J.R. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7, 195, 2011.
23. Li, T.Z., Kim, J.H., Cho, H.H., Lee, H.S., Kim, K.S., Lee, S.W., and Suh, H. Therapeutic potential of bone-marrow-derived mesenchymal stem cells differentiated with growth-factorfree coculture method in liver-injured rats. Tissue Eng Part A 16, 2649, 2010.
24. Tsai, P.C., Fu, T.W., Chen, Y.M., Ko, T.L., Chen, T.H., Shih, Y.H., Hung, S.C., and Fu, Y.S. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 15, 484, 2009.
25. Campard, D., Lysy, P.A., Najimi, M., and Sokal, E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134, 833, 2008.
26. Mitry, R.R. Isolation of human hepatocytes. Methods Mol Biol 481, 17, 2009.
27. Duan, Y., Catana, A., Meng, Y., Yamamoto, N., He, S., Gupta, S., Gambhir, S.S., and Zern, M.A. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 25, 3058, 2007.
28. Seglen, P.O. Preparation of isolated rat liver cells. Methods Cell Biol 13, 29, 1976.
29. Wu, Y.H., Zhang, X.M., Hu, M.H., Wu, X.M., and Zhao, Y. Effect of Laggera alata on hepatocyte damage induced by carbon tetrachloride in vitro and in vivo. J Ethnopharmacol 126, 50, 2009.
30. van Poll, D., Parekkadan, B., Cho, C.H., Berthiaume, F., Nahmias, Y., Tilles, A.W., and Yarmush, M.L. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47, 1634, 2008.
31. Dhawan, A., Puppi, J., Hughes, R.D., and Mitry, R.R. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 7, 288, 2010.
32. Bernal, W., Auzinger, G., Dhawan, A., and Wendon, J. Acute liver failure. Lancet 376, 190, 2010.
33. Hatzistergos, K.E., Quevedo, H., Oskouei, B.N., Hu, Q., Feigenbaum, G.S., Margitich, I.S., Mazhari, R., Boyle, A.J., Zambrano, J.P., Rodriguez, J.E., Dulce, R., Pattany, P.M., Valdes, D., Revilla, C., Heldman, A.W., McNiece, I., and Hare, J.M. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107, 913, 2010.
34. Chen, K., Wang, D., Du, W.T., Han, Z.B., Ren, H., Chi, Y., Yang, S.G., Zhu, D., Bayard, F., and Han, Z.C. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol 135, 448, 2010.
35. Bassi, E.J., de Almeida, D.C., Moraes-Vieira, P.M., and Camara, N.O. Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells. Stem Cell Rev 2011. [In press]
36. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E.D., and Deschaseaux, F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25 high FOXP3 + regulatory T cells. Stem Cells 26, 212, 2008.
37. Ortiz, L.A., Dutreil, M., Fattman, C., Pandey, A.C., Torres, G., Go, K., and Phinney, D.G. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104, 11002, 2007.
38. Volkmann, X., Anstaett, M., Hadem, J., Stiefel, P., Bahr, M.J., Lehner, F., Manns, M.P., Schulze-Osthoff, K., and Bantel, H. Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 47, 1624, 2008.
39. Deuse, T., Stubbendorff, M., Tang-Quan, K., Phillips, N., Kay, M.A., Eiermann, T., Phan, T.T., Volk, H.D., Reichenspurner, H., Robbins, R.C., and Schrepfer, S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20, 655, 2011.
40. Yan, Y., Xu, W., Qian, H., Si, Y., Zhu, W., Cao, H., Zhou, H., and Mao, F. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int 29, 356, 2009.
41. Caplan, A.I., and Dennis, J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98, 1076, 2006.